← All stocks

Rezolute, Inc.

RZLT Net buying

CIK 0001509261 #3185 in the set updated 21 Sep 2026

Bought (120 mo)

$51.51M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

+$51.51M

+$51.51M against sales at will

By person

13 insiders · 145 transactions

2.8×

Nevan Charles Elam holds only 2.8 times base salary in stock. $1.73M of shares against $610.83K in salary for 2025.

Salary from the company's own proxy. The shares are what Nevan Charles Elam last reported holding, valued at $2.85, the price Common Shares was last bought or sold at on the open market here, on 30 Mar 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

HANDOK, INC. entity

Director

$30.53M (72)

—

+$30.53M

5,942,617

6.17%

$16.94M

—

Genexine Inc. entity

10% owner

$10.00M (1)

—

+$10.00M

91,300,933

94.82%

$260.21M

—

Kim Young-Jin

Director

$9.37M (4)

—

+$9.37M

8,594,336

8.93%

$24.49M

+44.6%

Evans Daron

CFO

$693.23K (19)

—

+$693.23K

418,400

0.4345%

$1.19M

—

Hogenhuis Wladimir

Director

$261.29K (7)

—

+$261.29K

119,675

0.1243%

$341.07K

—

ROBERTS BRIAN KENNETH

Chief Medical Officer

$246.46K (19)

—

+$246.46K

295,227

0.3066%

$841.40K

—

Labrucherie Gil M

Director

$200.00K (1)

—

+$200.00K

55,500

0.0576%

$158.18K

—

Elam Nevan C

CEO

$94.28K (3)

—

+$94.28K

605,497

0.6288%

$1.73M

+21,394%

Welch David F

Director

$85.70K (16)

—

+$85.70K

3,645,930

3.79%

$10.39M

+2.5%

Karnawat Sunil Ratilal

Chief Commercial Officer

$19.60K (2)

—

+$19.60K

79,173

0.0822%

$225.64K

+541.6%

KREHER NERISSA

Director

$10.00K (1)

—

+$10.00K

58,576

0.0608%

$166.94K

—

FAUCHET PHILIPPE

Director

—

55,500

0.0576%

$158.18K

—

Harris Erik

Director

—

21,000

0.0218%

$59.85K

—

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 153

Amendments (4/A) skipped 3

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 115,083,740

History held since 13 Jan 2017